91 related articles for article (PubMed ID: 12604435)
21. Novel mutations in the FLT3 gene in adult patients with refractory acute myeloid leukemia.
Choi Y; Kim HJ; Park BH; Min WS; Kim CC
Leukemia; 2005 Jan; 19(1):141-3. PubMed ID: 15510198
[No Abstract] [Full Text] [Related]
22. Flt3 mutations and leukaemia.
Kottaridis PD; Gale RE; Linch DC
Br J Haematol; 2003 Aug; 122(4):523-38. PubMed ID: 12899708
[No Abstract] [Full Text] [Related]
23. Activating FLT3 mutations are rare in children with juvenile myelomonocytic leukemia.
Gratias EJ; Liu YL; Meleth S; Castleberry RP; Emanuel PD
Pediatr Blood Cancer; 2005 Feb; 44(2):142-6. PubMed ID: 15390271
[TBL] [Abstract][Full Text] [Related]
24. Low frequency of FLT3 gene internal tandem duplication and activating loop mutation in therapy-related acute myelocyticleukemia and myelodysplastic syndrome.
Au WY; Fung AT; Ma ES; Liang RH; Kwong YL
Cancer Genet Cytogenet; 2004 Mar; 149(2):169-72. PubMed ID: 15036894
[TBL] [Abstract][Full Text] [Related]
25. FLT3 mutation and response to intensive chemotherapy in young adult and elderly patients with normal karyotype.
Beran M; Luthra R; Kantarjian H; Estey E
Leuk Res; 2004 Jun; 28(6):547-50. PubMed ID: 15120929
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the activating mutations within the activation loop of leukemia targets Flt-3 and c-Kit based on protein homology modeling.
Torrent M; Rickert K; Pan BS; Sepp-Lorenzino L
J Mol Graph Model; 2004 Oct; 23(2):153-65. PubMed ID: 15363457
[TBL] [Abstract][Full Text] [Related]
27. Flt3/Itd mutation is not associated with gastrointestinal stromal tumors (gists).
Shiozawa E; Takimoto M; Makino R; Hirayama Y; Ota H
J Gastroenterol Hepatol; 2005 Jul; 20(7):1132-4. PubMed ID: 15955231
[No Abstract] [Full Text] [Related]
28. FLT3 mutations do not influence MDR-1 gene expression in acute myeloid leukemia.
Galimberti S; Rossi A; Palumbo GA; Morabito F; Guerrini F; Vincelli I; Fazzi R; Santini V; Petrini M
Anticancer Res; 2003; 23(4):3419-26. PubMed ID: 12926083
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotypic findings in acute myeloid leukemia with FLT3 internal tandem duplication.
Muñoz L; Aventín A; Villamor N; Juncà J; Acebedo G; Domingo A; Rozman M; Torres JP; Tormo M; Nomdedéu JF
Haematologica; 2003 Jun; 88(6):637-45. PubMed ID: 12801839
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of FLT3 mutations in pediatric non-promyelocytic acute myeloid leukemia.
Kang HJ; Hong SH; Kim IH; Park BK; Han KS; Cho HI; Shin HY; Ahn HS
Leuk Res; 2005 Jun; 29(6):617-23. PubMed ID: 15863200
[TBL] [Abstract][Full Text] [Related]
31. Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemia.
Stirewalt DL; Meshinchi S; Kussick SJ; Sheets KM; Pogosova-Agadjanyan E; Willman CL; Radich JP
Br J Haematol; 2004 Feb; 124(4):481-4. PubMed ID: 14984498
[TBL] [Abstract][Full Text] [Related]
32. Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype.
Neben K; Schnittger S; Brors B; Tews B; Kokocinski F; Haferlach T; Müller J; Hahn M; Hiddemann W; Eils R; Lichter P; Schoch C
Oncogene; 2005 Feb; 24(9):1580-8. PubMed ID: 15674343
[TBL] [Abstract][Full Text] [Related]
33. [Mutations of the gene coding for the receptor tyrosine kinase FLT3 in acute myeloid leukemia. Significance as the disease-specific molecular marker for diagnosis, prognosis and innovative therapy approaches].
Spiekermann K; Hiddemann W; Schnittger S
Dtsch Med Wochenschr; 2005 Apr; 130(16):1020-5. PubMed ID: 15830315
[No Abstract] [Full Text] [Related]
34. The role of FLT3 in haematopoietic malignancies.
Stirewalt DL; Radich JP
Nat Rev Cancer; 2003 Sep; 3(9):650-65. PubMed ID: 12951584
[TBL] [Abstract][Full Text] [Related]
35. Cooperative group tissue banks as research resources: the cancer and leukemia group B tissue repositories.
Schilsky RL; Dressler LM; Bucci D; Monovich L; Jewell S; Suster S; Caligiuri MA; Kantoff PW; Compton C
Clin Cancer Res; 2002 May; 8(5):943-8. PubMed ID: 12006505
[No Abstract] [Full Text] [Related]
36. In vitro activity of the flt3-inhibitor su5614 and standard cytotoxic agents in tumour cells from patients with wild type and mutated flt3 acute myeloid leukaemia.
Aleskog A; Höglund M; Pettersson J; Hermansson M; Larsson R; Lindhagen E
Leuk Res; 2005 Sep; 29(9):1079-81. PubMed ID: 16038735
[TBL] [Abstract][Full Text] [Related]
37. Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC.
Bianchini M; Ottaviani E; Grafone T; Giannini B; Soverini S; Terragna C; Amabile M; Piccaluga PP; Malagola M; Rondoni M; Bosi C; Baccarani M; Martinelli G
Clin Chem; 2003 Oct; 49(10):1642-50. PubMed ID: 14500589
[TBL] [Abstract][Full Text] [Related]
38. Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia.
Shih LY; Kuo MC; Liang DC; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Lai CL
Cancer; 2003 Sep; 98(6):1206-16. PubMed ID: 12973844
[TBL] [Abstract][Full Text] [Related]
39. Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations.
Oyarzo MP; Lin P; Glassman A; Bueso-Ramos CE; Luthra R; Medeiros LJ
Am J Clin Pathol; 2004 Sep; 122(3):348-58. PubMed ID: 15362364
[TBL] [Abstract][Full Text] [Related]
40. Novel FLT3 point mutation in acute myeloid leukaemia.
Piccaluga PP; Bianchini M; Martinelli G
Lancet Oncol; 2003 Oct; 4(10):604. PubMed ID: 14554237
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
